Structures by: Poirier M.

Total: 8

6-methyl-2-(3-methyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)pyrimidin-4(3H)-one

C13H16N4O

Poirier, MarionPujol-Giménez, JonaiManatschal, CristinaBühlmann, SvenEmbaby, AhmedJavor, SachaHediger, Matthias A.Reymond, Jean-Louis

RSC Medicinal Chemistry (2020)

a=8.1640(3)Å   b=8.5511(4)Å   c=19.8770(7)Å

α=93.396(3)°   β=99.154(3)°   γ=117.195(4)°

6-ethyl-4-hydroxy-2-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)pyrimidin-1-ium

Cl,C10H13N4O2,H2O

Poirier, MarionPujol-Giménez, JonaiManatschal, CristinaBühlmann, SvenEmbaby, AhmedJavor, SachaHediger, Matthias A.Reymond, Jean-Louis

RSC Medicinal Chemistry (2020)

a=8.66205(5)Å   b=14.39226(6)Å   c=9.94738(4)Å

α=90°   β=90.8062(4)°   γ=90°

2-(exo-mercapto)-2'-thioxo-(1R, 1R')-3-(exo),3'-(exo)-bibornanyl

C20H32S2

Kwiatkowski, W.Cameron, T. S.Salama, P.Poirier, M.

Acta Crystallographica Section C (1997) 53, 3 387-391

a=12.092(4)Å   b=20.540(2)Å   c=7.772(2)Å

α=90.00°   β=90.00°   γ=90.00°

2-dehydro-2,2'-(exo)-epidithio-3,3'-bibornane

C20H30S2

Kwiatkowski, W.Cameron, T. S.Salama, P.Poirier, M.

Acta Crystallographica Section C (1997) 53, 3 387-391

a=11.353(4)Å   b=22.289(2)Å   c=7.468(1)Å

α=90.00°   β=90.00°   γ=90.00°

2-(endo),2'-(exo)-epidithio-3,3'-bibornanylidene

C20H30S2

Kwiatkowski, W.Cameron, T. S.Salama, P.Poirier, M.

Acta Crystallographica Section C (1997) 53, 3 387-391

a=12.335(1)Å   b=21.044(2)Å   c=7.293(2)Å

α=90.00°   β=90.00°   γ=90.00°

C11H14O4S

C11H14O4S

Stéphane PerreaultMaude PoirierPascal LévielléOlivier RenéPascal JolyYves DoryClaude Spino

Journal of Organic Chemistry (2008) 73, 7457-7466

a=7.5897(8)Å   b=9.957(6)Å   c=15.340(3)Å

α=90°   β=99.483(11)°   γ=90°

C12H14O6S

C12H14O6S

Stéphane PerreaultMaude PoirierPascal LévielléOlivier RenéPascal JolyYves DoryClaude Spino

Journal of Organic Chemistry (2008) 73, 7457-7466

a=10.055(7)Å   b=12.797(9)Å   c=10.247(6)Å

α=90°   β=92.85(6)°   γ=90°